Galapagos NV ADR (GLPG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GLPG | ZBIO | MAZE | ||
| Company | Galapagos NV ADR | Zenas Biopharma Inc | Maze Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 31.43 | 39.11 | 41.41 | ||
| High | 31.81 | 39.46 | 41.80 | ||
| Low | 31.41 | 37.78 | 40.54 | ||
| Latest | 31.63 | 38.17 | 40.76 | ||
| Change | +0.14 | -1.19 | -0.70 | ||
| % Change | +0.44% | -3.02% | -1.69% | ||
| Volume | 66,300 | 224,100 | 293,900 | ||
| 20-Day Average Volume | 115,270 | 317,285 | 435,050 | ||
| Previous Close | 31.49 | 39.37 | 41.46 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 31.29 | 37.11 | 36.77 | ||
| 20-Day Raw Stochastic | 50.17% | 64.02% | 80.96% | ||
| 20-Day Relative Strength | 49.56 | 59.32 | 69.65 | ||
| Weighted Alpha | +18.11 | +345.71 | +119.22 | ||
| Today's Opinion | 8% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 8% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 24% Buy | 100% Buy | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.89% since 12/02/25 | +10.65% since 12/02/25 | +9.36% since 12/02/25 | ||
| Low | 31.19 on 12/03/25 | 34.50 on 12/03/25 | 37.45 on 12/03/25 | ||
| High | 31.98 on 12/04/25 | 41.50 on 12/08/25 | 43.29 on 12/04/25 | ||
| 1-Month | |||||
| %Chg | +0.32% since 11/07/25 | +13.58% since 11/07/25 | +42.52% since 11/07/25 | ||
| Low | 30.13 on 11/20/25 | 32.26 on 11/11/25 | 28.17 on 11/10/25 | ||
| High | 33.12 on 11/12/25 | 41.50 on 12/08/25 | 43.29 on 12/04/25 | ||
| 3-Month | |||||
| %Chg | -3.18% since 09/09/25 | +74.79% since 09/09/25 | +149.45% since 09/09/25 | ||
| Low | 29.81 on 11/05/25 | 18.24 on 09/16/25 | 15.70 on 09/10/25 | ||
| High | 37.78 on 10/03/25 | 41.50 on 12/08/25 | 43.29 on 12/04/25 | ||
| 6-Month | |||||
| %Chg | +12.60% since 06/09/25 | +220.26% since 06/09/25 | +218.19% since 06/09/25 | ||
| Low | 26.62 on 06/23/25 | 8.91 on 07/02/25 | 9.83 on 06/25/25 | ||
| High | 37.78 on 10/03/25 | 41.50 on 12/08/25 | 43.29 on 12/04/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,075,191 | 2,113,074 | 1,995,013 | ||
| Shares Outstanding, K | 65,900 | 53,679 | 48,119 | ||
| Annual Sales | 298,280,000 | 5,000,000 | 167,500,000 | ||
| Annual Net Income | 80,160,000 | -156,990,000 | 52,230,000 | ||
| Last Quarter Sales | 78,990,000 | 0 | 0 | ||
| Last Quarter Net Income | -161,610,000 | -52,220,000 | -30,090,000 | ||
| 60-Month Beta | 0.18 | -1.62 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.47 on 04/23/25 | -1.22 on 11/12/25 | -0.66 on 11/06/25 | ||
| Latest Earnings Date | 11/05/25 | 02/11/26 | 03/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 12/24/19 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||